-+ 0.00%
-+ 0.00%
-+ 0.00%

JOHNSON & JOHNSON SAYS ORAL ICOTROKINRA APPROVED IN CHINA FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS - STATEMENT

Reuters·08/27/2026 08:47:22

Please log in to view news